Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Antimicrobial resistance mechanism

10,941 views

Published on

for MD pharmacology

Published in: Health & Medicine
  • Odd Morning Hack Helps Mom of 3 Lose 62lbs (See Before/After pics)  http://t.cn/Airf776j
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • thank you
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • How can I sharpen my memory? How can I improve forgetfulness? find out more... ♥♥♥ https://tinyurl.com/brainpill101
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Hello, I'm 45 and have battled with severe Yeast Infection for the last nine years. A month and a half ago, I stumbled across your Yeast Infection No More program. I had my doubts and didn't think it was the right program for my Yeast Infection or if it was going to work at all, but I did order it because I'll do anything to rid myself of this crippling condition. Over 3 week period, I have seen an improvement that I had never experienced with any other conventional or so called natural treatment. The non-stop vaginal itching and burning have stopped. My skin looks significantly better and I slowly got rid of the psoriasis on my right elbow that I had for years. I can now save the money that I would have wasted on drugs like Monistat and Diflucan. Your suggestions have kept my vaginal yeast infections as well as the other candida related symptoms at bay incredibly well! I also lost about 15 lbs! I am feeling so healthy, too. ♣♣♣ https://tinyurl.com/y3flbeje
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • I have started the program this September and I must say I'm very pleased with the results. I was overweight and sick from candida and had severe swelling, and redness in the vulva area including vaginal discharge. Using your program I have lost a TON of weight. I no longer itch and scratch. The vaginal discharge had stopped and I'm feeling better than ever. I have also found through your book that some of my other health problems are from candida yeast overgrowth. My acid reflux and my skin texture had dramatically improved and I feel awesome physically. ♣♣♣ http://scamcb.com/index7/pdf
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here

Antimicrobial resistance mechanism

  1. 1. ANTIMICROBIAL RESISTANCE MECHANISMS - Dr Mangala Nischal
  2. 2. CONTENTS :- • Introduction • Natural Resistance • Acquired Resistance • Resistance Mechanisms - Biochemical - Mutation - Gene Transfer • Cross Resistance • Prevention of Drug Resistance
  3. 3. INTRODUCTION :- • WHO - Defines as micro-organisms that are not inhibited by usually achievable systemic concentration of an antimicrobial agent(AMA) with normal dosage schedule and / or fall in the minimum inhibitory concentration (MIC) range. • when a species is subjected to chemical warfare, that threatens its extinction it often evolves mechanisms to survive under that stress development of resistance.
  4. 4. • Two major factors are associated with emergence of antibiotic resistance: - Evolution - Clinical/ Environmental practices.
  5. 5. NATURAL RESISTANCE :- • Some microbes lack the metabolic process or the target site for particular drug. • e.g: - Gram-negative bacilli are normally unaffected by penicillin G - M. tuberculosis is insensitive to tetracyclines. • This resistance does not pose a significant clinical problem.
  6. 6. ACQUIRED RESISTANCE :- • It is the development of resistance by an organism (which was sensitive before) due to the prolonged use of an AMA. • Some bacteria are notorious for rapid acquisition of resistance e.g. staphylococci, coliforms, tubercle bacilli.
  7. 7. RESISTANCE MECHANISMS :- BIOCHEMICAL MECHANISMS - • Antimicrobial resistance can develop at any one or more of steps in the process • Reduced entry of antibiotic into pathogen • Enhanced export of antibiotic by efflux pumps • Release of microbial enzymes that destroy the antibiotic
  8. 8. • Alteration of microbial proteins that transform pro-drugs to the effective moieties • Alteration of target proteins • Development of alternative pathways to those inhibited by the antibiotic
  9. 9.  Reduced Entry of Drug into Pathogen :- • Small polar molecules & antibiotics, enter the cell through protein channels called Porins. • Absence of, mutation in, or loss of a favored porin channel can slow the rate of drug entry into a cell or prevent entry altogether  reducing drug concentration at the target site. • If target is intracellular  mutation or phenotypic change that slows or abolishes this transport mechanism  resistance.
  10. 10.  Resistance Due to Reduced Affinity of Drug to Altered Target Structure :- • A reduced affinity of drug for its target or the enzyme that converts the prodrug to active drug. Such alterations may be due to  Mutation of the natural target (e.g., fluoroquinolone resistance)  Target modification (e.g., ribosomal protection type of resistance to macrolides and tetracyclines) Acquisition of a resistant form of the native, susceptible target (e.g., staphylococcal methicillin resistance caused by production of a low-affinity penicillin-binding protein)
  11. 11. • Examples :- • The penicillin-resistant gonococci are less permeable to penicillin G. • Chloroquine-resistant P. Falciparum accumulates less chloroquine.
  12. 12.  Resistance Due to Drug Efflux :- • Microorganisms can overexpress efflux pumps and then expel antibiotics to which their susceptible. • Five major systems of efflux pumps - The multidrug and toxic compound extruder (MATE) - The major facilitator superfamily (MFS) transporters - The small multidrug resistance (SMR) system - The resistance nodulation division (RND) exporters - ATP binding cassette (ABC) transporters
  13. 13. • Drug resistance to erythromycin, fluoroquinolones & Anti-malarial drugs are mediated through these Efflux pumps.
  14. 14.  Resistance Due to Destruction of Antibiotic :- • Drug inactivation is a common mechanism of drug resistance. • Bacterial resistance to aminoglycosides  aminoglycoside-modifying enzyme • β -lactam antibiotics  β -lactamase
  15. 15.  Hetero-resistance and Viral Quasi Species :- • It is said to be present when only a subset of the total microbial population is resistant. • Increased therapeutic failures and mortality is seen. • Viral evolution due to drug and immune pressure  Quasi species. • Quasi species are resistant to antiretroviral agents  failure of antiretroviral therapy.
  16. 16.  Resistance due to Enhanced Excision of incorporated drug :- • These drugs are incorporated into the viral DNA chain and cause chain termination. • E.g. Nucleoside reverse transcriptase inhibitors such as zidovudine are 2′-deoxyribonucleoside analogs  5′-triphosphate and compete with natural nucleotides.
  17. 17.  MUTATION – • Mutation and antibiotic selection of the resistant mutant are the molecular basis for development of resistance in many bacteria, viruses, and fungi. • Mutations are not caused by drug exposure. They occur as a survival advantage, when drug is present.
  18. 18. • Mutations may occur in the gene encoding (1) The target protein, altering its structure so that it no longer binds the drug (2) A protein involved in drug transport (3) A protein important for drug activation or inactivation (4) In a regulatory gene or promoter gene affecting expression of the target, a transport protein, or an inactivating enzyme
  19. 19. • Suboptimal dosing strategies  selective kill of the more susceptible population, which leaves the resistant isolates to flourish. • A single-step mutation  high degree of resistance. • The Multi-step mutation  clinically significant resistance. • E.g : Combination of pyrimethamine and sulfadoxine inhibits Plasmodium falciparum’s folate biosynthetic pathway via inhibition of dihydrofolate reductase (DHFR) by pyrimethamine and dihydropteroate synthetase (DHPS) by sulfadoxine.
  20. 20.  Hypermutable Phenotypes :- • The ability to protect genetic information from disintegrating and also to be flexible enough to allow genetic changes. • This is accomplished principally by the - Insertion of the correct base pair by DNA polymerase III - Proofreading by the polymerase - Postreplicative repair. • Mutator (Mut) phenotypes  antibiotic resistance .
  21. 21. Quorum sensing :- • Microbes communicate with each other and exchange signaling chemicals (Autoinducers) coordinate gene expression for virulence, conjugation, apoptosis, mobility and resistance. • QS signal molecules AHL, AIP, AI-2 & AI-3 have been identified in GM-ve bacteria • Gram-positive bacteria use processed oligo-peptides to communicate.
  22. 22. • Several QS inhibitors molecules have been synthesized  AHL, AIP, and AI-2 analogues  Potent Virulence inhibitors. • QS controls virulence factor production in Gram-positive human pathogens including S. aureus, Listeria monocytogenes, Enterococcus faecalis, and Clostridium perfringens • V. cholera, P. aeruginosa  Gram negative bacteria .
  23. 23.  GENE TRANSFER :- • Drug resistance may be acquired by passage of the trait vertically to daughter cells, but more commonly it is acquired by horizontal transfer of resistance by, - Transduction - Transformation - Conjugation
  24. 24. • Horizontal transfer of resistance genes is greatly facilitated by Mobile genetic elements Plasmids Transducing Transposable Integrons Gene phages elements cassettes Insertion sequences Transposons Transposable phages
  25. 25. • Insertion sequences do not encode resistance, but they function as sites for integration of other resistance-encoding elements. • Transposons are insertion sequences that also code for drug resistance & other function. • Transposon move between chromosome and plasmid thus “hitchhike” the resistant gene out of the host and into a recipient.
  26. 26.  Transduction - Is acquisition of bacterial DNA from a phage that has incorporated DNA from a previous resistant host bacterium. e.g. strains of S. aureus.
  27. 27. Transformation - Is the uptake and incorporation into the host genome by free DNA released into the environment by other bacterial cells. E.g. Penicillin resistance in Pneumococci and Neisseria.
  28. 28. Conjugation - Is gene transfer by direct cell-to-cell contact through a sex pilus or bridge. • Multiple resistance genes can be transferred in a single event. • Genetic transfer by conjugation is common among gram-negative bacilli, and Enterococci.
  29. 29. CROSS RESISTANCE :- • Acquisition of resistance to one AMA conferring resistance to another AMA to which the organism has not been exposed e.g. - resistance to one sulfonamide means resistance to all others, -resistance to one tetracycline means insensitivity to all others • Partial cross resistance is sometimes seen in unrelated drugs e.g. - between tetracyclines and chloramphenicol - between erythromycin and lincomycin.
  30. 30. • Cross resistance may be  Two-way, e.g. between erythromycin and clindamycin and vice versa  One-way, e.g. development of neomycin resistance by enterobacteriaceae makes them insensitive to streptomycin but many streptomycin-resistant organisms remain susceptible to neomycin.
  31. 31. Prevention of drug resistance :-  No indiscriminate and inadequate or unduly prolonged use of AMAs should be made.  Prefer rapidly acting and selective (narrow spectrum) AMAs.  Use combination of AMAs for prolonged therapy e.g. tuberculosis, SABE.  Intensive treatment for notorious organisms.
  32. 32. REFERENCES :- • Essentials of Medical Pharmacology Sixth Edition - KD TRIPATHI MD • Goodman & Gilman’s The Pharmacological Basis of THERAPEUTICS • LaSarre B, Federle MJ. Exploiting Quorum Sensing To Confuse Bacterial Pathogens. Microbiology and Molecular Biology Reviews : MMBR. 2013;77(1):73-111. doi:10.1128/MMBR.00046-12.

×